Double-Blind, Placebo-Controlled Trial of Eefooton in Patients With Chronic Kidney Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chen-Shiung Wu, Ph.D
Taichung Tzu Chi Hospital
Study Director - Ching-Hsiu Peng, MD
Taichung Tzu Chi Hospital
Principal Investigator - Ding-Jun Lin Lin, MD
Taichung Tzu Chi Hospital
Principal Investigator - Ko-Lin Kuo, MD
Taichung Tzu Chi Hospital
Principal Investigator - Kuo-Cheng Lu, Ph.D
Taichung Tzu Chi Hospital
Study Chair - Szu-Chun Hung, MD
Taichung Tzu Chi Hospital
Principal Investigator - Yi-Chun Wang, MD
Taichung Tzu Chi Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Nephrology, Taipei Tzu Chi Hospital, Taipei, Taiwan
Taipei County, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2022
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2024
- Last update posted
- 2 Mar 2022
- Registered enrollment
- 120
- Registry id
- NCT05227313
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.